SMSPHARMA

SMS Pharmaceuticals Share Price

 

 

Invest in SMS Pharmaceuticals with 2.65X leverage

Invest with MTF

Performance

  • Low
  • ₹312
  • High
  • ₹322
  • 52 Week Low
  • ₹176
  • 52 Week High
  • ₹335
  • Open Price₹321
  • Previous Close₹322
  • Volume366,533

Investment Returns

  • Over 1 Month + 12.87%
  • Over 3 Month + 34.18%
  • Over 6 Month + 27.08%
  • Over 1 Year + 22.51%

Smart Investing Starts Here Start SIP with SMS Pharmaceuticals for Steady Growth!

Invest Now

SMS Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 33.3
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 2,810
  • P/B Ratio
  • Average True Range
  • 14.03
  • EPS
  • 9.01
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 7.22
  • RSI
  • 61.82
  • MFI
  • 84.33

SMS Pharmaceuticals Financials

SMS Pharmaceuticals Technicals

EMA & SMA

Current Price
₹317.00
-5.45 (-1.69%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹302.40
  • 50 Day
  • ₹288.33
  • 100 Day
  • ₹273.95
  • 200 Day
  • ₹260.08

Resistance and Support

316.98 Pivot Speed
  • R3 331.17
  • R2 326.43
  • R1 321.72
  • S1 312.27
  • S2 307.53
  • S3 302.82

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

SMS Pharmaceuticals Ltd. is a prominent Indian pharmaceutical company specializing in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on quality, innovation, and regulatory compliance, catering to both domestic and international markets in the healthcare sector.

Sms Pharmaceuticals has an operating revenue of Rs. 860.03 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 12% is healthy, ROE of 10% is good. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 13% and 30% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 41 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

SMS Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-08 Quarterly Results
2025-08-09 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
2025-05-30 Audited Results & Final Dividend
2025-02-12 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
2024-11-08 Quarterly Results
Date Purpose Remarks
2025-09-22 FINAL Rs.0.40 per share(40%)Final Dividend
2024-09-23 FINAL Rs.0.40 per share(40%)Final Dividend
2023-09-22 FINAL Rs.0.30 per share(30%)Final Dividend
2022-09-23 FINAL Rs.0.30 per share(30%)Final Dividend
View SMS Pharmaceuticals Dividend History Arrow

SMS Pharmaceuticals F&O

SMS Pharmaceuticals Shareholding Pattern

68.07%
2.88%
0.28%
24.02%
4.75%

About SMS Pharmaceuticals

  • NSE Symbol
  • SMSPHARMA
  • BSE Symbol
  • 532815
  • Chairman & Managing Director
  • Mr. Ramesh Babu Potluri
  • ISIN
  • INE812G01025

Similar Stocks to SMS Pharmaceuticals

SMS Pharmaceuticals FAQs

SMS Pharmaceuticals share price is ₹317 As on 06 December, 2025 | 12:05

The Market Cap of SMS Pharmaceuticals is ₹2810.3 Cr As on 06 December, 2025 | 12:05

The P/E ratio of SMS Pharmaceuticals is 33.3 As on 06 December, 2025 | 12:05

The PB ratio of SMS Pharmaceuticals is 5 As on 06 December, 2025 | 12:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23